[First results of symptom statistical studies on the characterization of the clinical effect profile of the antidepressive agent noxiptilin].
D000328:Adult; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy*; D003693:Delirium / Q000139:chemically induced; D003863:Depression / Q000188:drug therapy*; D003986:Dibenzocycloheptenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004361:Drug Tolerance; D005260:Female; D005385:Fingers; D006801:Humans; D008297:Male; D008875:Middle Aged; D019965:Neurocognitive Disorders / Q000188:drug therapy*; D010554:Personality Disorders / Q000188:drug therapy*; D011618:Psychotic Disorders / Q000188:drug therapy*; D012559:Schizophrenia / Q000188:drug therapy*; D013546:Sweating; D013997:Time Factors; D014202:Tremor / Q000139:chemically induced; D014555:Urination Disorders / Q000139:chemically induced; D014717:Vertigo / Q000139:chemically induced; D014786:Vision Disorders / Q000139:chemically induced
D000928:Antidepressive Agents; D003986:Dibenzocycloheptenes
Erste Ergebnisse symptomstatistischer Untersuchungen zur Charakterisierung des klinischen Wirkungsprofils des Antidepressivums Noxiptilin.